| Sources | Names Used |
|---|---|
| CTRPv2 | PRL-3 inhibitor I |
| PharmacoGx | PRL-3 Inhibitor I |
| Database | Identifier |
|---|---|
| Smiles: | Brc1ccc(OCc2ccccc2Br)c(/C=C3/SC(=S)NC3=O)c1 |
| Pubchem: | 11983303 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHF12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | RHBDL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | OR51J1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | OLFML3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PHKA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | DDX53 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BICDL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | NOSIP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | MET | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PIFO | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
